EXACTIS
LIVE

Serial Number

86534923

Owner

Innovation Exactis

Attorney

Christie Baty Hudgins

Filing Date

Feb 13, 2015

Add to watchlist:

No watchlists yet
View on USPTO

EXACTIS Trademark

Serial Number: 86534923 • Registration: 5505700

EXACTIS is a trademark filed by Innovation Exactis on February 13, 2015. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Innovation Exactis

5450 Chemin de la Côte-des-Neiges
Montréal, Québec H3T1Y6 , CA

Entity Type: 03

Trademark Details

Filing Date

February 13, 2015

Registration Date

July 3, 2018

Published for Opposition

April 17, 2018

Goods & Services

[ Financial sponsorship of clinical and translational trials in the field of cancer treatment ]

Promoting collaboration and the exchange of information and resources within the scientific, research, medical, clinical and private communities to achieve advances in the field of cancer treatment; Providing pharmacoeconomic information in the nature of medical and/or research data pertaining to cancer and its treatment

Providing medical information with profiles of cancer patients' tumours and the associated clinical and molecular data, cancer drugs, biomarkers, biological and tissue samples, and results of clinical studies, via an on-line searchable database; Providing tissue biobank services, namely, access to a biobank of human biological and tissue samples; Providing medical information concerning quality of life in the fields of the treatment of cancer, the likelihood of success of the treatment of cancer, the physical and psychological impacts of the treatment of cancer on patients and the recovery time from the treatment of cancer; Providing medical information in the nature of medical data pertaining to cancer and its treatment; Providing psychosocial care information in the nature of medical data pertaining to cancer and its treatment; Providing medical information about pharmacovigilance in the nature of medical data pertaining to cancer and its treatment

Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; Medical and scientific research in the field of cancer treatment; Providing research information in the nature of medical research data pertaining to cancer and its treatment; Management of clinical and translational trials in the field of cancer treatment for others; Providing clinical trial information in the nature of research data pertaining to cancer

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 10, 2024 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 10, 2024 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 2, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 20, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 3, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 14, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 14, 2018 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2018 COAR
REGISTERED-PRINCIPAL REGISTER
Jul 3, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 17, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 28, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 13, 2017 GNRN
NON-FINAL ACTION E-MAILED
Sep 13, 2017 GNRT
NON-FINAL ACTION WRITTEN
Sep 13, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 24, 2017 CRFA
ASSIGNED TO LIE
Aug 14, 2017 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 18, 2017 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 10, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 10, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
May 10, 2017 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 4, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 4, 2016 GNSL
SUSPENSION LETTER WRITTEN
Nov 4, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2016 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 3, 2016 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 4, 2016 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 4, 2016 GNSI
SUSPENSION INQUIRY WRITTEN
May 4, 2016 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 3, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 3, 2015 GNSL
SUSPENSION LETTER WRITTEN
Nov 3, 2015 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 20, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2015 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2015 GNRT
NON-FINAL ACTION WRITTEN
May 21, 2015 CNRT
ASSIGNED TO EXAMINER
May 20, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2015 NWOS
NEW APPLICATION ENTERED
Feb 17, 2015 NWAP